Blood derivative in-vitro diagnostic substances manufacturing

NAICS 325413

Workplace safety data for employers in this industry

Employers
232
Avg TCR (this industry)
1.8
BLS Benchmark
3.3
national average
Total Injuries
3,606

What Blood derivative in-vitro diagnostic substances manufacturing Safety Data Reveals

The Blood derivative in-vitro diagnostic substances manufacturing sector (NAICS 325413) encompasses 232 distinct employer establishments currently reporting to OSHA's Injury Tracking Application. Across this cohort, workers have logged 3,606 recordable injuries during the 2016–2024 reporting window, producing an industry-weighted average Total Case Rate (TCR) of 1.8 injuries per 100 full-time workers per year. Because OSHA's ITA mandates submission from establishments with 250+ employees plus all high-hazard industries at 20+ employees, this dataset represents a structural slice of U.S. workplace risk rather than a voluntary sample.

The Bureau of Labor Statistics publishes a separate national benchmark TCR of 3.3 for this NAICS code, derived from the BLS Survey of Occupational Injuries and Illnesses. Comparing the two, the ITA-reported rate of 1.8 is below the BLS benchmark — a gap that typically widens when the industry contains many large, high-exposure establishments required to file ITA reports. Employers in the table below are sorted so you can see how far individual establishments deviate from both the industry average and the national benchmark.

The practical value of industry-level safety data is threefold. First, jobseekers can gauge whether a prospective employer is better or worse than its industry peers — not just absolute injury counts, which tilt toward larger payrolls. Second, insurers and workers' compensation carriers use sector TCR as a baseline for experience-modification adjustments. Third, safety professionals benchmark their own programs against the cohort median. Use the grade-sorted employer list below to identify specific establishments within Blood derivative in-vitro diagnostic substances manufacturing that outperform or underperform the sector average, and click through to each record for year-by-year injury, illness, and fatality breakdowns.

Employers by Safety Rate (Page 5 of 5)

Employer Location Avg TCR Grade
Becton Dickinson Caribe LTD.- Biosciences CAYEY, PR 0.2 A
Immucor GTI Diagnostics (Waukesha) WAUKESHA, WI 0.0 C
Cerilliant Corporation (411 W Main, Round Rock Branch Office) ROUND ROCK, TX 0.0 C
Biolog, Inc. HAYWARD, CA 0.0 C
DRG International, Inc. SPRINGFIELD, NJ 0.0 C
ZeptoMetrix LLC (an antylia scientific Company) FRANKLIN, MA 0.0 C
ZeptoMetrix Buffalo BUFFALO, NY 0.0 C
PTS Diagnostics - SV SUNNYVALE, CA 0.0 C
Agdia Inc ELKHART, IN 0.0 C
OriGene Technologies, Inc ROCKVILLE, MD 0.0 C
SDIX - Newark NEWARK, DE 0.0 C
Meridian Bioscience Corp CINCINNATI, OH 0.0 C
IDT Boulder BOULDER, CO 0.0 C
Immucor Mt. View MT. VIEW, CA 0.0 C
Princeton Biomeditech Corporation MONMOUTH JUNCTION, NJ 0.0 C
Fuller Laboratories FULLERTON, CA 0.0 C
Syntron Bioresearch, Inc. CARLSBAD, CA 0.0 C
Biovest International, Inc COON RAPIDS, MN 0.0 C
Anaerobe Systems MORGAN HILL, CA 0.0 C
Processing Center IBBI MEMPHIS, TN 0.0 C
Biohelix BEVERLY, MA 0.0 C
Bio SB, Inc. SANTA BARBARA, CA 0.0 C
NOWDiagnostics Inc. SPRINGDALE, AR 0.0 C
LBS MARYLAND HEIGHTS, MO 0.0 C
Corning, Inc. Woburn WOBURN, MA 0.0 C
Zeptometrix FRANKLIN, MA 0.0 C
EKF Diagnostics Life Sciences ELKHART, IN 0.0 C
Cygnus Technologies, LLC SOUTHPORT, NC 0.0 C
Siwa Biotech OKLAHOMA CITY, OK 0.0 C
Maine Standards Company, LLC CUMBERLAND FORESIDE, ME 0.0 C
Sunnyvale - Elko SUNNYVALE, CA 0.0 C
Bion Enterprises, Ltd. (DBA - MBL Bion) DES PLAINES, IL 0.0 C
BD Durham DURHAM, NC 0.0 C
Sekisui Diagnostics Lexington LEXINGTON, MA 0.0 C
Immucor Waukesha WAUKESHA, WI 0.0 C
← Prev Page 5 of 5

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainSafetyScore Editorial

Verify with BLS →

Verify with OSHA →